Preimpantation Diagnosis (PGD) is available on-site at EMBIO IVF, which has one of the largest and most experienced PGD laboratories. PGD is a form of prenatal diagnosis performed on early embryos prior to implantation in the uterus and initiation of pregnancy. When using PGD, only embryos of the desired gender are returned to the uterus, giving a nearly 100% accuracy rate. PGD can be used to prevent genetic diseases passed from parents to children.
Developed by GIVF, MicroSort® is GIVF’s exclusive preconception technology for sorting sperm to increase the likelihood of conceiving a child of a particular gender. MicroSort® may be of particular interest to patients with a family history of gender-linked genetic disease. Currently in clinical trial, MicroSort® is available only to patients who meet the requirements for clinical trial participation. MicroSort®’s patented technology separates sperm into those that produce females and those that produce males. Sorted specimens enriched in male or female-producing sperm are then used for intrauterine insemination or for in-vitro fertilization. Study data so far indicate that patients who wish to have a girl are successful in conceiving a female baby 9 out of 10 times; those seeking a boy are successful approximately 3 out of 4 times.
Participation in the clinical trial is limited to married couples with a documented history of gender-linked disease.
Dr Paraschos participated in the world's first PGD.